Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
Cohen JA; Cutter GR; Fischer JS; Goodman AD; Heidenreich FR; Jak AJ; Kniker JE; Kooijmans MF; Lull JM; Sandrock AW; Simon JH; Simonian NA; Whitaker JN; Archives Of Neurology, 2001, vol. 58, issue 6, p 961, ISSN 00039942. ISBN 00039942.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef